Under visible light, adding the nickel-cobalt cocatalyst increased the hydrogen evolution rate by approximately ten times ...

ANSTO is embarking on a major decommissioning project which will officially mark the end of an era for Australia’s first nuclear research reactor at Lucas Heights, the High Flux Australian Reactor ...

The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian ...

ANSTO’s new facility uses ANSTO Synroc technology to immobilise waste from the production of molybdenum-99, known as SyMo, is a global, first-of-a-kind operational Synroc plant. Molybdenum-99, ...

Silicon irradiation also known as Neutron Transmutation Doping (NTD), is conducted in the OPAL reactor. Through this process thermal neutrons react with the silicon atoms, changing some of those atoms ...

Designed for Radiation Safety Officers working in industrial settings responsible for radioactive substances and/or radiation apparatus. ANSTO is a recognised leader in radiation safety training, ...

ANSTO conducts and enables inter-disciplinary research using nuclear and isotopic techniques to address some of Australia’s and the world’s most challenging environmental problems, focusing on water ...

The researchers found that colonialisation drove cascading changes: increased fire temperature, a four-fold increase in eucalypt cover, transformation from an open woodland to forest, and increased ...

The Australian Nuclear science and Technology Organisation (ANSTO) has been steadily building Australia’s nuclear expertise over the past 70 years. Today, despite being small in scale, Australia is ...

ANSTO’s capabilities to support additive manufacturing have been greatly strengthened with the installation of the first-in-the-world custom-built powder Laser Metal Deposition (LMD) system that can ...

ANSTO congratulated the Peter Macallum Cancer Centre led team, who recently reported the remarkable results of late-stage prostate cancer clinical trials at an international conference this month. The ...